Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma
Clinical trial NCT05201859 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05201859
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2026-03-02
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.